MINI FUTURE OPTIONSSCHEIN - BOSTON SCIENTIFIC | Real-time Bid/Ask 12:01:49 2024-07-12 pm EDT | ||
| 4.22 EUR / 4.23 EUR | +0.84% |
|
| Current month | -1.64% | ||
| 1 month | -2.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 4.21 | +0.48% |
| 24-07-11 | 4.19 | -0.24% |
| 24-07-10 | 4.2 | +0.96% |
| 24-07-09 | 4.16 | +0.48% |
| 24-07-08 | 4.14 | -0.72% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 12:01 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JB1T8U |
| ISIN | DE000JB1T8U2 |
| Date issued | 2023-09-29 |
| Strike | 31.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.36 € |
|---|---|
| Lowest since issue | 1.85 € |
| Spread | 0.01 € |
| Spread % | 0.24% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.89
USD
Average target price
82.81
USD
Spread / Average Target
+7.70%
- Stock Market
- Certificates
- Certificat
